Academic and industrial partners

As part of its research activities, the SIRIC BRIO develops multiple partnerships with academic and industrial teams on topics of interest to the scientific and medical community and which enhance the value of Bordeaux expertise at all levels of the chain value of research (preclinical research, clinical research, start-ups, epidemiological studies and post-marketing authorization, real-life data …).

The multidisciplinary nature of the research teams as well as the funding obtained by INCa, Inserm and DGOS are major assets for carrying out our collaborative programs. Indeed, BRIO brings together experts in multiple fields of oncology research: oncologists, surgeons, anatomopathologists, radiologists and radiotherapists, fundamental researchers in biology, chemistry, physics, mathematics, human and social sciences, philosophy …

SIRIC financing is used to initiate many innovative research projects that can be subsequently promoted through the establishment of strategic collaborations with industrial or academic partners whose skills are complementary to local teams.

Our academic partners

BRIO has already built several fundamental and clinical research collaborations with oncology expert centers. Thus we collaborate with other SIRICs and various academic partners in many forms:

  • Clinical research partnerships to carry out tests or implement clinico-biological databases (onco-geriatrics, sarcomas, glioblastoma, urological cancers …).

The UroCCR database and biological collection created by Professor Jean-Christophe Bernhard (urologist surgeon at the University Hospital Center) is a key clinical-biological database for all translational research projects in onco-urology and included in the COMMUCAN program. .

  • Translational and fundamental research projects (New Aquitaine cancer network, Cancéropôle Grand Sud-Ouest, European consortia, national networks such as the sarcomas network or onco-geriatrics).

A translational research collaboration was set up between the Bordeaux teams and SIRIC Montpellier on the theme of colon cancer via the Montpellier clinical-biological database.

Research staff shared between the Institut Gustave Roussy and Marseille / Bordeaux in Humanities and Social Sciences, collaboration with the Cordeliers center (team of Pr Hervé and Catherine Friedman) and the team sarcomas / early trials of Pr Italiano.

Collaboration with the Basque Country and Navarre within the ONCONAEN network (geriatric oncology).

  • Highlighting Bordeaux platforms combining technical expertise and clinical-biological know-how:


Immunology at the CHU

BioPathology of the Bergonié Institute

  • Solicitation of local experts for regional, national and international interventions for congresses. We also regularly invite local or national experts to maintain a strong link with French, European and international cancer research actors.

ONCOSPHERE conferences, intervention of SIRIC representatives from the HEGP, Lyon and Pitié-Salpétrière at the “BRIGHT DAYS”, UroCCR scientific day, early testing day of the Institut Bergonié …

Our industrial partners

BRIO and the cancer community of Bordeaux work in close collaboration with multiple industrial partners. Indeed, the complementarity of expertise between academic and industrial research is a strong point on which BRIO relies to carry out its collaborative programs.

At the local level, we work closely with research promotion units (SATT Nouvelle Aquitaine, INSERM transfer, CNRS innovation, UNITEC, MATWIN …). We have integrated several endogenous and exogenous start-ups into our research programs (TreeFrog, Oncoprot, Mypl, ImmusMol, CelloMet …).

We also work closely with pharmaceutical companies that provide access to oncology clinical clinical trials for patients in the region, help us co-develop innovative research programs, and energize the community by partnering with many innovative translational research projects and events.

Our International Scientific Board now includes 2 industrial representatives.

So BRIO offers industrialists:

  • a rich and multidisciplinary ecosystem of oncology research bringing together multiple medical, scientific and start-up health experts
  • the possibility of carrying out co-development programs for innovative molecules or setting up new methods of treatment in partnership with our local clinical research teams
  • Clinical teams with a strong capacity to carry out tests from the early phase to the post-AMM studies (labeling CLIP2 CHU and Institut Bergonié in March 2019, obtaining the pediatric CLIP2, ISPED …)
  • collaborate to set up scientific and medical events to discuss together the main themes that animate the cancer community but also work for events for the general public and for patients such as the evening ASPERON and Co or the video project around clinical studies.

Becoming partner

The BRIO community is open for any academic or industrial research collaboration. BRIO is today a group of more than 50 doctors, surgeons, pathologists, a hundred researchers, doctoral and post-doctoral students, advanced platforms, start-ups and technological know-how. These strong links with hospital and university structures as well as with major research organizations such as Inserm, CEA or CNRS, the Nouvelle-Aquitaine region, the GSO cancer research center, research development structures, etc. are real assets for carrying out collaborative research projects with high added value for cancer patients.

You can specifically contact the BRIO team who will make the link with the researcher, the doctor or the platform with whom you wish to collaborate. Thus, we will be able to organize you a telephone meeting, an appointment and direct you towards the most suitable person to exchange. The very good knowledge of the fabric of cancer research in Bordeaux is an asset for the BRIO team, which has also managed to forge strong links with the Bordeaux research community.

For any setting up or possible partnership proposals, contact us:

Academic / Industrial Research Partnerships
Christelle LIARD

Partnerships on scientific events / patient partnership
Lise MOLIMARD et Nathalie CAPLET